Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

PURPOSE: To update eligibility and outcome measures in trials that evaluate systemic treatment for patients with progressive prostate cancer and castrate levels of testosterone. METHODS: A committee of investigators experienced in conducting trials for prostate cancer defined new consensus criteria...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Scher, Howard I., Halabi, Susan, Tannock, Ian, Morris, Michael, Sternberg, Cora N., Carducci, Michael A., Eisenberger, Mario A., Higano, Celestia, Bubley, Glenn J., Dreicer, Robert, Petrylak, Daniel, Kantoff, Philip, Basch, Ethan, Kelly, William Kevin, Figg, William D., Small, Eric J., Beer, Tomasz M., Wilding, George, Martin, Alison, Hussain, Maha
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4010133/
https://ncbi.nlm.nih.gov/pubmed/18309951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.12.4487
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados